NCT03560557View on ClinicalTrials.gov

Optimization of PK/PD Target Attainment for Meropenem in Critically Ill Patients With Sepsis

CompletedOBSERVATIONAL
Enrollment

116

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

October 31, 2017

Study Completion Date

October 31, 2017

Conditions
Critical IllnessPharmacokinetics
All Listed Sponsors
lead

Universitaire Ziekenhuizen KU Leuven

OTHER

NCT03560557 - Optimization of PK/PD Target Attainment for Meropenem in Critically Ill Patients With Sepsis | Biotech Hunter | Biotech Hunter